1. |
Wilhelm H, Schabet M. The diagnosis and treatment of optic neuritis[J]. Dtsch Arztebl Int, 2015, 112(37): 616-626. DOI: 10.3238/arztebl.2015.0616.
|
2. |
中华医学会眼科分学会神经眼科学组, 兰州大学循证医学中心/世界卫生组织指南实施与知识转化合作中心. 中国脱髓鞘性视神经炎诊断和治疗循证指南(2021年)[J]. 中华眼科杂志, 2021, 57(3): 171-186. DOI: 10.3760 /cma.j.cn 112142-20201124-00769.Neuro-ophthalmology Group of Ophthalmology Branch of Chinese Medical Association, Evidence-based Medicine Center of LanzhouUniversity/World Health Organization Collaborating Centre for Guideline Implementation and Knowledge Translation. Evidence based guidelines for diagnosis and treatment of demyelinating optic neuritis in China (2021)[J]. Chin J Ophthalmol, 2021, 57(3): 171-186. DOI: 10.3760 /cma.j.cn 112142-20201124-00769.
|
3. |
Fujihara K. Neuromyelitis optica and astrocytic damage in its pathogenesis[J]. J Neurol Sci, 2011, 306(1-2): 183-187. DOI: 10.1016/j.jns.2011.02.018.
|
4. |
Takano R, Misu T, Takahashi T, et al. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study[J]. Neurology, 2010, 75(3): 208-216. DOI: 10.1212/WNL.0b013e3181e2414b.
|
5. |
宋宏鲁, 魏世辉, 孙明明, 等. 《中国脱髓鞘性视神经炎诊断和治疗循证指南(2021年)》解读[J]. 中华眼底病杂志, 2021, 37(10): 753-757. DOI: 10.3760/cma.j.cn511434-20210830-00475.Song HL, Wei SH, Sun MM, et al. Interpretation of an evidence-based guideline for the diagnosis and treatment of demyelinating optic neuritis in China (2021)[J]. Chin J Ocul Fundus Dis, 2021, 37(10): 753-757. DOI: 10.3760/cma.j.cn511434-20210830-00475.
|
6. |
Saadoun S, Papadopoulos MC. Role of membrane complement regulators in neuromyelitis optical[J]. Mult Scler, 2015, 21(13): 1644-1654. DOI: 10.1177/1352458515571446.
|
7. |
Quek AM, McKeon A, Lennon VA, et al. Effects of age and sex on aquaporin-4 autoimmunity[J]. Arch Neurol, 2012, 69(8): 1039-1043. DOI: 10.1001/ archneurol.2012.249. DOI: 10.1001/archneurol.2012.249.
|
8. |
中华医学会眼科学分会神经眼科学组. 视神经炎诊断和治疗专家共识(2014年)[J]. 中华眼科杂志, 2014, 50(6): 459-463. DOI: 10.3760/cma.j.issn.0412-4081.2014.06.013.Neuroophthalmology Group, Society of Ophthalmology, Chinese Medical Association. Expert consensus on the diagnosis and treatment of optic neuritis (2014)[J]. Chin J Ophthalmol, 2014, 50(6): 459-463. DOI: 10.3760/cma.j.issn.0412-4081.2014.06.013. DOI: 10.3760/cma.j.issn.0412-4081.2014.06.013.
|
9. |
Issa N, Martin C, Dulau C, et al. Severe anti-GFAP meningo-encephalomyelitis following viral infection[J/OL]. Mult Scler Relat Disord, 2020, 45: 102448[2020-08-19]. https://pubmed.ncbi.nlm.nih.gov/32827972/. DOI: 10.1016/j.msard.2020.102448.
|
10. |
Handoko M, Hong W, Espineli E, et al. Autoimmune glial fibrillary acidic protei-n astrocytopathy following herpes simplex virus encephalitis in a pediatric patient[J]. Pediatr Neurol, 2019, 98: 85-86. DOI: 10.1016/j.pediatrneurol.2019.05.010.
|
11. |
Long Y, Liang J, Xu H, et al. Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective study[J]. Eur J Neurol, 2018, 25(3): 477-483. DOI: 10.1111/ene.13531.
|
12. |
Fang B, McKeon. A, Hinson SR, et al. Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoen-cephalomyelitis[J]. JAMA Neurol, 2016, 73(11): 1297-1307. DOI: 10.1001/jamaneurol.2016.2549.
|
13. |
高丰, 刘华. 自身免疫性胶质纤维酸性蛋白星形细胞病的研究进展[J]. 中风与神经疾病杂志, 2021, 38(4): 383-384. DOI: 10.19845/j.cnki.zfysjjbzz.2021.0103.Gao F, Liu H. Advances in the study of autoimmune glial fibrillary acidic protein astrocytoma[J]. J Apoplexy and Nervous Diseases, 2021, 38(4): 383-384. DOI: 10.19845/j.cnki.zfysjjbzz.2021.0103.
|
14. |
Flanagan EP, Hinson SR, Lennon VA, et al. GFAP-IgG as biomarker of autoimmune astrocytopathy: analysis of 102 patients[J]. Ann Neurol, 2017, 81(2): 298-309. DOI: 10.1002/ana.24881.
|
15. |
Abdelhak A, Foschi M, Abu-Rumeileh S, et al. Blood GFAP as an emerging biomarker in brain and spinal cord disorders[J]. Nat Rev Neurol, 2022, 18(3): 158-172. DOI: 10.1038/s41582-021-00616-3.
|
16. |
Storoni M, Petzold A, Plant GT. The use of serum glial fibrillary acidic protein measurements in the diagnosis of neuromyelitis optica spectrum optic neuritis[J/OL]. PLoS One, 2011, 6(8): e23489[2011-08-18]. https://pubmed.ncbi.nlm.nih.gov/21876753/. DOI: 10.1371/journal.pone.0023489.
|
17. |
Storoni M, Verbeek MM, Illes Z, et al. Serum GFAP levels in optic neuropathies[J]. J Neurol Sci, 2012, 317(1-2): 117-122. DOI: 10.1016/j.jns.2012.02.012.
|
18. |
中国免疫学会神经免疫学分会, 中华医学会神经病学分会神经免疫学组, 中国医师协会神经内科分会神经免疫专业委员会. 中国视神经脊髓炎谱系疾病诊断与治疗指南[J]. 中国神经免疫学和神经病学杂志, 2016, 23(3): 155-165. DOI: 10.3969/j.issn.1006-2963.2016.03.001.Neuroimmunology Branch of Chinese Society of Immunology, Neuroimmunology Group of Neurology Branch of Chinese Medical Association, Neuroimmunology Professional Committee of Neurology Branch of Chinese Medical Doctor Association, Chinese Medical Doctor Association. Guidelines for diagnosis and treatment of neuromyelitis spectrum diseases in China[J]. Chin J Neuroimmunol & Neurol, 2016, 23(3): 155-165. DOI: 10.3969/j.issn.1006-2963.2016.03.001.
|